| View |
|
DRP-2373-07
|
FOLIC ACID
|
Folivit
|
5 mg
|
Capsule
|
VITAMINS/HEMATINICS
|
LifeSquare Laboratories, Inc
|
Philippines
|
Renewal
|
29 February 2024
|
26 May 2029
|
| View |
|
DRP-2821-09
|
Ambroxol hydrochloride
|
Ambroppex
|
15 mg/5 mL
|
Syrup
|
Mucolytic
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
20 October 2023
|
23 December 2025
|
| View |
|
DRP-3353-04
|
Multivitamins + Iron (see reverse)
|
Euroferron Forte
|
|
Capsule
|
Vitamins and Mineral
|
Lloyd Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
23 October 2023
|
28 July 2025
|
| View |
|
DRP-3685-05
|
Simvastatin
|
Squastatin
|
20 mg
|
Tablet
|
HMG-CoA Reductase Inhibitor
|
LifeSquare Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
20 October 2023
|
28 October 2028
|
| View |
|
DRP-5762-03
|
Ambroxol Hydrochloride
|
None
|
15mg/5mL
|
Syrup (Cherry Flavor)
|
Mucolytic
|
J.M. Tolmann Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
23 October 2023
|
10 October 2027
|
| View |
|
DRP-6075-04
|
Thiamine Mononitrate (Vitamin B1) + Pyridoxine Hydrochloride (Vitamin B6) + Cyanocobalamin (Vitamin B12)
|
Lifevitz
|
200mg/200mg/1mg
|
Capsule
|
Vitamins
|
LifeSquare Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
18 October 2023
|
25 March 2028
|
| View |
|
DRP-6570-11
|
Cefuroxime (as Sodium)
|
Cefopsiv
|
750 mg
|
Powder for Injection (I.M./I.V.)
|
Antibacterial
|
NCPC Hebei Huamin Pharmaceutical Co., Ltd.
|
China
|
Automatic Renewal
|
24 January 2024
|
10 March 2029
|
| View |
|
DRP-7406-05
|
Metformin Hydrochloride
|
Metromet
|
500 mg
|
Film-Coated Tablet
|
Oral Hypoglycemic
|
Hizon Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
22 October 2023
|
12 January 2027
|
| View |
|
DRP-7734-05
|
Dexamethasone + Neomycin (as sulfate) + Polymyxin-BSulfate
|
Goxetrol
|
1 mg/3.5 mg/6000
|
I.U. Ophthalmic & Otic Suspension
|
Corticosteroid/Anti-Infective
|
Egyptian International Pharmaceutical Industries Co.
|
Egypt
|
CLIDP Conversion
|
19 October 2023
|
16 March 2028
|
| View |
|
DRP-8044-03
|
Tobramycin
|
Tobrago
|
3 mg/mL (0.3 % w/v)
|
Sterile Ophthalmic Solution (Eye Drops)
|
Antibacterial (Aminoglycoside)
|
Egyptian International Pharmaceutical Industries Co. (EIPICO)
|
Egypt
|
CLIDP Conversion
|
19 October 2023
|
05 December 2028
|
| View |
|
DRP-8493-01
|
Pantoprazole (as sodium sesquihydrate)
|
Ulcapep
|
40 mg
|
Enteric-Coated Tablet
|
Proton Pump Inhibitor
|
Bioveeta Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
19 October 2023
|
01 December 2024
|
| View |
|
DRP-884-07
|
Cefuroxime (as Sodium)
|
Altoxime
|
750 mg
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Cephalosporin)
|
Daewon Pharm. Co., Ltd.
|
Korea
|
CLIDP Conversion
|
22 October 2023
|
28 September 2027
|
| View |
|
DRP-8985-07
|
Losartan potassium
|
Goztan-50
|
50 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker
|
Zim Laboratories Ltd.
|
India
|
CLIDP Conversion
|
18 October 2023
|
21 July 2025
|
| View |
|
DRP-909-09
|
Cloxacillin (as sodium)
|
Seaclox
|
500 mg
|
Capsule
|
Antibacterial (Penicillin)
|
Lloyd Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
18 October 2023
|
10 November 2026
|
| View |
|
DRP-9166-05
|
Clopidogrel
|
Clopitor
|
75 mg
|
Film-Coated Tablet
|
Antithrombotic Agent (Platelet Aggregation Inhibitor)
|
Zim Laboratories Limited
|
India
|
CLIDP Conversion
|
18 October 2023
|
21 December 2025
|
| View |
|
DRP-9262-04
|
Citicoline (as Sodium)
|
Reticoline
|
500 mg
|
Film-Coated Tablet
|
Psychostimulant/Nootropic
|
Saga Lifesciences Limited
|
India
|
CLIDP Conversion
|
18 October 2023
|
09 November 2025
|
| View |
|
HRP-031-05
|
Carbocisteine
|
Mucostan
|
100mg/5mL
|
Syrup
|
Mucolytic
|
J.M. Tolmann Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
18 October 2023
|
12 November 2026
|
| View |
|
HRP-256-03
|
POVIDONE-IODINE
|
DSINFEX
|
75 mg / mL (7.5 % w/v)
|
Topical Solution
|
ANTISEPTIC
|
LifeSquare Laboratories, Inc
|
Philippines
|
Renewal
|
18 April 2024
|
06 May 2029
|
| View |
|
HRP-256-04
|
POVIDONE-IODINE
|
Lifedex
|
75mg/mL (7.5% w/v)
|
Topical Solution
|
ANTISEPTIC
|
LifeSquare Laboratories, Inc
|
Philippines
|
Renewal
|
17 April 2024
|
06 May 2029
|
| View |
|
DR-XY23414
|
Meropenem (As Trihydrate)
|
Meronem
|
500 mg
|
Powder For Injection (I.V.)
|
-
|
ACS Dobfar S.P.A.
|
Italy
|
Automatic Renewal
|
30 March 2021
|
10 February 2026
|